Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myrcludex B vs Entecavir in HBeAg Negative Chronic Hepatitis B
NCT02881008Phase 2Completed
- Sponsor
- Hepatera
- Start
- Nov 2012
- Primary completion
- Oct 2014
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of bulevirtide in Chronic Hepatitis B (CHB), sponsored by Hepatera. Started Nov 2012; status: completed.
02
Drugs
bulevirtide
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02881008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02881008.